CHARLES CUPP: Open Payments
NPI 1811675960 · LOUDON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $113 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $93 |
| Lilly USA, LLC | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Eisai Inc. | 1 | $29 |
| Amgen Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: LEQVIO, Ozempic, JARDIANCE, GEMTESA, Leqembi, Wegovy, Rybelsus, ZEPBOUND.
Industry payments across TN — which companies pay providers there.
